PMID: 42211143

Cardiovascular Risk Reduction With Tirzepatide, a Dual GIP/GLP-1 Agonist, in Patients With Type 2 Diabetes Mellitus.

Terui Sakiko, Minami Taichi, Nakamura Keita, Terauchi Yasuo

Journal of lipid and atherosclerosis · 2026

Vol. 15, Issue 2, pp. 249-260

View on PubMedDOI

This entry links to third-party literature. For research use only.

For research use only. This index links to third-party literature. Nothing here constitutes medical advice.